Literature DB >> 18392664

Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study.

A Ishani1, M Paudel, B C Taylor, E Barrett-Connor, S Jamal, M Canales, M Steffes, H A Fink, E Orwoll, S R Cummings, K E Ensrud.   

Abstract

UNLABELLED: Older men with reduced renal function are at increased risk of hip bone loss. Given the robustness of this association across different measures and a growing body of literature, our findings indicate that clinicians should take into account renal function when evaluating older men for osteoporosis risk and bone loss. Future randomized controlled trials should test whether interventions in this high risk population are effective in preventing bone loss and decreasing fracture incidence.
INTRODUCTION: Studies examining whether kidney impairment, not requiring dialysis, is associated with osteoporosis have reported conflicting results.
METHODS: We tested the hypothesis that reduced renal function in older men as manifested by higher concentrations of cystatin C or lower levels of estimated glomerular filtration rate (eGFR) is associated with higher rates of bone loss. We measured serum cystatin C, serum creatinine and total hip bone mineral density (BMD) at baseline in a cohort of 404 older men enrolled in the Osteoporotic Fractures in Men (MrOS) Study and followed them prospectively for an average of 4.4 years for changes in BMD. Associations between renal function and change in hip BMD were examined using linear regression.
RESULTS: In multivariable analysis, the mean rate of decline in total hip BMD showed an increase in magnitude with higher cystatin C concentration (mean annualized percent change -0.29, -0.34, -0.37 and -0.65% for quartiles 1 to 4; p for trend=0.004). Similarly, adjusted rates of hip bone loss were higher among men with lower eGFR as defined by the modification of diet in renal disease formula (mean annualized percent change -0.58, -0.39, -0.37, and -0.31 for quartiles 1 to 4; p for trend=0.02), but not among men with lower eGFR as defined by the Cockcroft-Gault formula (mean annualized percent change -0.47, -0.44, -0.31 and -0.43 for quartiles 1 to 4; p for trend=0.48).
CONCLUSIONS: Older men with reduced renal function are at increased risk of hip bone loss. Our findings suggest that health care providers should consider renal function when evaluating older men for risk factors for bone loss and osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392664     DOI: 10.1007/s00198-008-0608-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  38 in total

1.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

2.  Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study.

Authors:  Ann M O'Hare; Anne B Newman; Ronit Katz; Linda F Fried; Catherine O Stehman-Breen; Stephen L Seliger; David S Siscovick; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2005 Dec 12-26

3.  Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men.

Authors:  Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

4.  Racial differences in bone mineral density and bone loss among end-stage renal disease patients.

Authors:  C O Stehman-Breen; D Sherrard; A Walker; R Sadler; A Alem; J Lindberg
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

5.  Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study.

Authors:  Simerjot K Jassal; Denise von Muhlen; Elizabeth Barrett-Connor
Journal:  J Bone Miner Res       Date:  2007-02       Impact factor: 6.741

6.  Increased risk of hip fracture among patients with end-stage renal disease.

Authors:  A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

Review 7.  The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease.

Authors:  Helga Refsum; Eha Nurk; A David Smith; Per M Ueland; Clara G Gjesdal; Ingvar Bjelland; Aage Tverdal; Grethe S Tell; Ottar Nygård; Stein E Vollset
Journal:  J Nutr       Date:  2006-06       Impact factor: 4.798

8.  Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C.

Authors:  E Wasén; R Isoaho; K Mattila; T Vahlberg; S-L Kivelä; K Irjala
Journal:  J Intern Med       Date:  2004-07       Impact factor: 8.989

9.  Effect of declining renal function on bone density in aging women.

Authors:  J R Buchanan; C A Myers; R B Greer
Journal:  Calcif Tissue Int       Date:  1988-07       Impact factor: 4.333

10.  Cystatin C as a risk factor for outcomes in chronic kidney disease.

Authors:  Vandana Menon; Michael G Shlipak; Xuelei Wang; Josef Coresh; Tom Greene; Lesley Stevens; John W Kusek; Gerald J Beck; Allan J Collins; Andrew S Levey; Mark J Sarnak
Journal:  Ann Intern Med       Date:  2007-07-03       Impact factor: 25.391

View more
  25 in total

Review 1.  Current status of bicarbonate in CKD.

Authors:  Mirela Dobre; Mahboob Rahman; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

2.  Association of Increased Urinary Albumin With Risk of Incident Clinical Fracture and Rate of Hip Bone Loss: the Osteoporotic Fractures in Men Study.

Authors:  Howard A Fink; Tien N Vo; Lisa Langsetmo; Joshua I Barzilay; Jane A Cauley; John T Schousboe; Eric S Orwoll; Muna T Canales; Areef Ishani; Nancy E Lane; Kristine E Ensrud
Journal:  J Bone Miner Res       Date:  2017-02-21       Impact factor: 6.741

3.  The utility of circulating markers to predict bone loss across the CKD spectrum.

Authors:  Thomas L Nickolas
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-19       Impact factor: 8.237

4.  Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?

Authors:  T Kwok; J Leung; Y F Zhang; D Bauer; K E Ensrud; E Barrett-Connor; P C Leung
Journal:  Osteoporos Int       Date:  2011-11-12       Impact factor: 4.507

5.  Predictors of change of trabecular bone score (TBS) in older men: results from the Osteoporotic Fractures in Men (MrOS) Study.

Authors:  J T Schousboe; T N Vo; L Langsetmo; B C Taylor; A M Kats; A V Schwartz; D C Bauer; J A Cauley; K E Ensrud
Journal:  Osteoporos Int       Date:  2017-10-31       Impact factor: 4.507

Review 6.  Fracture risk assessment in patients with chronic kidney disease.

Authors:  S A Jamal; S L West; P D Miller
Journal:  Osteoporos Int       Date:  2011-09-08       Impact factor: 4.507

7.  Rapid cortical bone loss in patients with chronic kidney disease.

Authors:  Thomas L Nickolas; Emily M Stein; Elzbieta Dworakowski; Kyle K Nishiyama; Mafo Komandah-Kosseh; Chiyuan A Zhang; Donald J McMahon; Xiaowei S Liu; Stephanie Boutroy; Serge Cremers; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

8.  Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men.

Authors:  Tracie C Collins; Susan K Ewing; Susan J Diem; Brent C Taylor; Eric S Orwoll; Steven R Cummings; Elsa S Strotmeyer; Kristine E Ensrud
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

9.  Intensive glycemic control and thiazolidinedione use: effects on cortical and trabecular bone at the radius and tibia.

Authors:  Ann V Schwartz; Eric Vittinghoff; Karen L Margolis; Lesley M Scibora; Lisa Palermo; Walter T Ambrosius; Trisha F Hue; Kristine E Ensrud
Journal:  Calcif Tissue Int       Date:  2013-02-05       Impact factor: 4.333

10.  Predictors of the rate of BMD loss in older men: findings from the CHAMP study.

Authors:  K Bleicher; R G Cumming; V Naganathan; M J Seibel; F M Blyth; D G Le Couteur; D J Handelsman; H M Creasey; L M Waite
Journal:  Osteoporos Int       Date:  2012-12-05       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.